Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024)
Galmed Pharmaceuticals (EOCN) reported EBIT of $1.82 million for FY2025, down 17.2% from $2.2 million in FY2024.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024) Analysis & Trends
Dating back to FY2011, Galmed Pharmaceuticals' EBIT record includes 15 years.
- EBIT has declined for four consecutive years, with a five-year compound annual growth rate of -43.0% (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual EBIT since FY2011.
- According to Business Quant data, EBIT came in at $2.2 million in FY2024 (-70.6%), $7.49 million in FY2023 (-57.6%), $17.65 million in FY2022 (-46.3%) and $32.88 million in FY2021 (+8.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Galmed Pharmaceuticals | 1.40 Mn | -43.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 653,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | -588,000.00 |
| Jun 30, 2022 | 286,000.00 |
| Mar 31, 2022 | -250,000.00 |
| Jun 30, 2020 | -5.82 Mn |
| Mar 31, 2020 | 6.46 Mn |
| Dec 31, 2019 | -32.64 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Jun 30, 2019 | -4.70 Mn |
| Mar 31, 2019 | 4.04 Mn |
| Dec 31, 2018 | -17.23 Mn |
| Sep 30, 2018 | 1.18 Mn |
| Jun 30, 2018 | -2.78 Mn |
| Mar 31, 2018 | 2.56 Mn |
| Dec 31, 2017 | -21.08 Mn |
| Sep 30, 2017 | 2.76 Mn |
| Jun 30, 2017 | -2.70 Mn |
| Mar 31, 2017 | 3.26 Mn |
| Dec 31, 2016 | 4.75 Mn |
API Access
Galmed Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();